PMID: 14211681Jun 1, 1964Paper

THE INHIBITORY ACTIONS OF PROSTAGLANDINS ON RESPIRATORY SMOOTH MUSCLE

British Journal of Pharmacology and Chemotherapy
I H MAIN

Abstract

Prostaglandin E(1), in concentrations as low as 1 ng/ml., relaxed isolated tracheal muscle from cat, monkey, rabbit, guinea-pig and ferret. Tracheal muscle from the cat, monkey and rabbit did not exhibit inherent tone and the effect of prostaglandin E(1) on these preparations was seen only after a sustained contraction had been produced by a previous dose of acetylcholine or of another agonist. Prostaglandins E(2), E(3) and F(1alpha) also relaxed isolated cat tracheal muscle which had been stimulated by acetylcholine: their activities relative to that of prostaglandin E(1) were, respectively, 1.0, 0.2 and 0.002. In the anaesthetized cat prostaglandin E(1) increased lung "resistance to inflation" (presumably comparable to bronchial resistance) and the heart rate. In the anaesthetized rabbit and guinea-pig, prostaglandin E(1) antagonized the rise in resistance to inflation of the lungs obtained after vagal stimulation or after the intravenous injection of histamine; it sometimes lowered the resistance to inflation in these species. The possibility that prostaglandin may have a local physiological role in the control of bronchial smooth muscle tone is discussed.

References

May 1, 1963·Acta Physiologica Scandinavica·E ANGGARD, S BERGSTROM
Aug 1, 1963·British Journal of Pharmacology and Chemotherapy·E W HORTON, I H MAIN
Nov 1, 1961·Biochemical Pharmacology·B O LINNH J ROBINSON

❮ Previous
Next ❯

Citations

Jan 1, 1983·European Journal of Clinical Pharmacology·N NaeijeR Sergijsels
Nov 1, 1985·Digestive Diseases and Sciences·J A Steiner
Jan 1, 1982·The Journal of Membrane Biology·P L SmithR A Frizzell
Jul 1, 1977·Agents and Actions·N Chand, P Eyre
Apr 1, 1979·Agents and Actions·P Eyre, N Chand
Mar 15, 1965·Experientia·E W Horton
Dec 1, 1974·European Journal of Pharmacology·H H Frey, A Schäfer
May 15, 1978·European Journal of Pharmacology·R D Krell
Mar 29, 1989·European Journal of Pharmacology·J MachováL Bilcíková
Mar 1, 1976·Prostaglandins·D W Hall, K D Jaitly
Dec 1, 1976·Prostaglandins·H KunzeD Le-Kim
Jan 1, 1979·Pharmacology & Therapeutics·H L Hahn, J A Nadel
Jan 1, 1989·Pharmacology & Therapeutics·P J Gardiner
Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·R T BrittainD Jack
Jan 1, 1976·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·J Iravani, G N Melville
Jan 1, 1977·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·P J Piper
Feb 26, 2000·European Journal of Pharmacology·M Richter, P Sirois
Feb 1, 1983·Prostaglandins, Leukotrienes, and Medicine·E W SpannhakeP J Kadowitz
Apr 14, 1977·The New England Journal of Medicine·A A MathéC A Leslie
Aug 1, 1975·British Journal of Clinical Pharmacology·M F Cuthbert
Aug 1, 1967·British Journal of Pharmacology and Chemotherapy·E W Horton, I H Main
Oct 1, 1974·British Journal of Pharmacology·R A Coleman, G P Levy
Sep 1, 1975·British Journal of Pharmacology·J B FarmerA M Woods
Jun 1, 1977·Acta Physiologica Scandinavica·K Strandberg, P Hedqvist
Jan 27, 1973·British Medical Journal·A A MathéN Svanborg
May 25, 2011·Thorax·James BuckleyMaria G Belvisi
Jan 1, 1974·Annals of the New York Academy of Sciences·S I SaidL D Holden
Dec 1, 1966·The Journal of Obstetrics and Gynaecology of the British Commonwealth·S M Karim
Jan 1, 1977·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·B G Simonsson, N Svedmyr
Jun 1, 1979·Prostaglandins and Medicine·R CeseraniS Bianco

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.